Show simple item record

dc.contributor.authorHanna, Jacob
dc.contributor.authorMarkoulaki, Styliani
dc.contributor.authorSchorderet, Patrick
dc.contributor.authorCarey, Bryce W.
dc.contributor.authorBeard, Caroline F.
dc.contributor.authorWernig, Marius
dc.contributor.authorCreyghton, Menno P.
dc.contributor.authorSteine, Eveline J.
dc.contributor.authorCassady, John P.
dc.contributor.authorForeman, Ruth K.
dc.contributor.authorLengner, Christopher Joachim
dc.contributor.authorDausman, Jessica A.
dc.contributor.authorJaenisch, Rudolf
dc.date2022-08-11T08:08:52.000
dc.date.accessioned2022-08-23T16:10:26Z
dc.date.available2022-08-23T16:10:26Z
dc.date.issued2008-04-22
dc.date.submitted2009-02-24
dc.identifier.citationCell. 2008 Apr 18;133(2):250-64. <a href="http://dx.doi.org/10.1016/j.cell.2008.03.028">Link to article on publisher's site</a>
dc.identifier.issn1097-4172 (Electronic)
dc.identifier.doi10.1016/j.cell.2008.03.028
dc.identifier.pmid18423197
dc.identifier.urihttp://hdl.handle.net/20.500.14038/32933
dc.description.abstractPluripotent cells can be derived from fibroblasts by ectopic expression of defined transcription factors. A fundamental unresolved question is whether terminally differentiated cells can be reprogrammed to pluripotency. We utilized transgenic and inducible expression of four transcription factors (Oct4, Sox2, Klf4, and c-Myc) to reprogram mouse B lymphocytes. These factors were sufficient to convert nonterminally differentiated B cells to a pluripotent state. However, reprogramming of mature B cells required additional interruption with the transcriptional state maintaining B cell identity by either ectopic expression of the myeloid transcription factor CCAAT/enhancer-binding-protein-alpha (C/EBPalpha) or specific knockdown of the B cell transcription factor Pax5. Multiple iPS lines were clonally derived from both nonfully and fully differentiated B lymphocytes, which gave rise to adult chimeras with germline contribution, and to late-term embryos when injected into tetraploid blastocysts. Our study provides definite proof for the direct nuclear reprogramming of terminally differentiated adult cells to pluripotency.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=18423197&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1016/j.cell.2008.03.028
dc.subjectAnimals; B-Lymphocytes; *Cell Differentiation; Cell Nucleus; Embryonic Stem Cells; Humans; Mice; Pluripotent Stem Cells; Transcription Factors
dc.subjectLife Sciences
dc.subjectMedicine and Health Sciences
dc.titleDirect reprogramming of terminally differentiated mature B lymphocytes to pluripotency
dc.typeJournal Article
dc.source.journaltitleCell
dc.source.volume133
dc.source.issue2
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/gsbs_sp/1485
dc.identifier.contextkey738050
html.description.abstract<p>Pluripotent cells can be derived from fibroblasts by ectopic expression of defined transcription factors. A fundamental unresolved question is whether terminally differentiated cells can be reprogrammed to pluripotency. We utilized transgenic and inducible expression of four transcription factors (Oct4, Sox2, Klf4, and c-Myc) to reprogram mouse B lymphocytes. These factors were sufficient to convert nonterminally differentiated B cells to a pluripotent state. However, reprogramming of mature B cells required additional interruption with the transcriptional state maintaining B cell identity by either ectopic expression of the myeloid transcription factor CCAAT/enhancer-binding-protein-alpha (C/EBPalpha) or specific knockdown of the B cell transcription factor Pax5. Multiple iPS lines were clonally derived from both nonfully and fully differentiated B lymphocytes, which gave rise to adult chimeras with germline contribution, and to late-term embryos when injected into tetraploid blastocysts. Our study provides definite proof for the direct nuclear reprogramming of terminally differentiated adult cells to pluripotency.</p>
dc.identifier.submissionpathgsbs_sp/1485
dc.contributor.departmentDepartment of Cell Biology
dc.contributor.departmentThe Whitehead Institute for Biomedical Research
dc.contributor.departmentGraduate School of Biomedical Sciences
dc.source.pages250-64


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record